Sequential proteome alterations during genesis and progression of colon cancer

Cellular and Molecular Life Sciences

Volumn 61, Issue 10, 2004, Pages 1246-1255

  Roblick, U J ^a,b   Hirschberg, D ^a   Habermann, J K ^a,c   Palmberg, C ^a   Becker, S ^a   Kruger S ^d   Gustafsson, M ^e   Bruch, H P ^b   Franzen B ^a,f   Ried, T ^c   Bergman, T ^a   Auer, G ^a   Jornvall H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF LÜBECK   (Germany)

^e Gyros AB   (Sweden)

^f ASTRAZENECA R AND D   (Sweden)

Author keywords

2 D gel electrophoresis; Colon cancer; Mass spectrometry; Proteomics; Tumor marker

Indexed keywords

PROTEOME;

ADENOMA; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER INVASION; CELL CYCLE; COLON CANCER; COLON MUCOSA; COMPACT DISK; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSKELETON; DISEASE COURSE; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MASS SPECTROMETRY; METASTASIS; MUCOSA CELL; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN METABOLISM; SIGMOID CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ADENOMA; AGED; AGED, 80 AND OVER; CARCINOMA; CELL NUCLEUS; COLONIC NEOPLASMS; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM METASTASIS; PEPTIDES; PLOIDIES; PROTEOME; UP-REGULATION;

SIGMOIDEA;

EID: 2542524556     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4049-4     Document Type: Article

References (27)

1. Fearon E. R. and Vogelstein B. (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
2. Sporn M. B. (1996) The war on cancer. Lancet 347: 1377-1381
3. Yeatman T. J. and Chambers A. F. (2003) Osteopontin and colon cancer progression. Clin. Exp. Metastasis 20: 85-90
4. Wallace H. M. and Caslake R. (2001) Polyamines and colon cancer. Eur. J. Gastroenterol. Hepatol. 13: 1033-1039
5. Srivastava S., Verma M. and Henson D. E. (2001) Biomarkers for early detection of colon cancer. Clin. Cancer Res. 7: 1118-1126
6. Franzen B., Linder S., Okuzawa K., Kato H. and Auer G. (1993) Nonenzymatic extraction of cells from clinical tumor material for analysis of gene expression by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 14: 1045-1053
7. Auer G. U., Caspersson T. O. and Wallgren A. S. (1980) DNA content and survival in mammary carcinoma. Anal. Quant. Cytol. 2: 161-165
8. Auer G. U., Arrhenius E., Granberg P. O. and Fox C. H. (1980) Comparison of DNA distributions in primary human breast cancers and their metastases. Eur. J. Cancer 16: 273-278
9. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254
10. Okuzawa K., Franzen B., Lindholm J., Linder S., Hirano T., Bergman T. et al. (1994) Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 15: 382-390
11. Morrissey J. H. (1981) Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal. Biochem. 117: 307-310
12. Rabilloud T., Vuillard L., Gilly C. and Lawrence J. J. (1994) Silver-staining of proteins in polyacrylamide gels: a general overview. Cell. Mol. Biol. 40: 57-75
13. Garrels J. I. (1989) The QUEST system for quantitative analysis of two-dimensional gels. J. Biol. Chem. 264: 5269-5282
14. Jocliffe I. T. (1986) Principal Component Analysis, Springer, New York
15. Oppermann M., Cols N., Nyman T., Helin J., Saarinen J., Byman I. et al. (2000) Identification of foetal brain proteins by two-dimensional gel electrophoresis and mass spectrometry comparison of samples from individuals with or without chromosome 21 trisomy. Eur. J. Biochem. 267: 4713-4719
16. Franzen B., Linder S., Alaiya A. A., Eriksson E., Uruy K., Hirano T. et al. (1996) Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins. Br. J. Cancer 74: 1632-1638
17. Ponten F., Berg C., Ahmadian A., Ren Z. P., Nister M., Lundeberg J. et al. (1997) Molecular pathology in basal cell cancer with p53 as a genetic marker. Oncogene 15: 1059-1067
18. Kern D. H. (1998) Heterogeneity of drug resistance in human breast and ovarian cancers. Cancer J. Sci. Am. 4: 41-45
19. Villavicencio R. T. and Rex D. K. (2000) Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy. Semin. Gastrointest. Dis. 11: 185-193
20. Chiosis G., Lucas B., Shtil A., Huezo H. and Rosen N. (2002) Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase. Bioorg. Med. Chem. 10: 3555-3564
21. (2002) Cancer vaccine-antigenetics. BioDrugs 16: 72-74
22. Nawrocki S., Murawa P., Malicki J., Kapcinska M., Gryska K., Izycki D. et al. (2000) Genetically modified tumour vaccines (GMTV) in melanoma clinical trials. Immunol. Lett. 74: 81-86
23. Nicchitta C. V. (2003) Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nat. Rev. Immunol. 3: 427-432
24. Rakonczay Z. Jr, Takacs T., Boros I. and Lonovics J. (2003) Heat shock proteins and the pancreas. J. Cell. Physiol. 195: 383-391
25. Berezowski K., Stastny J. F. and Kornstein M. J. (1996) Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod. Pathol. 9: 426-429
26. Jooss K. U. and Muller R. (1995) Deregulation of genes encoding microfilament-associated proteins during Fos-induced morphological transformation. Oncogene 10: 603-608
27. Wang Y., Han K. J., Pang X. W., Vaughan H. A., Qu W., Dong X. Y. et al. (2002) Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J. Immunol. 169: 1102-1109